Results 41 to 50 of about 133,448 (228)
“Endolymphatic sac tumour”: A case report with review of literature
Indian Journal of Pathology and Microbiology, 2019 Endolymphatic sac tumour (ELST) is a non-metastasizing low grade adenocarcinoma of endolymphatic sac origin. It is also known as Heffner tumour, low grade adenocarcinoma of endolymphatic sac origin and aggressive papillary middle ear tumour.
B Rajeshwari +4 more
doaj +1 more source
Endolymphatic sac tumor: rewiev of literature
Медицинский совет, 2022 Endolymphatic sac tumors are rare neoplasms of the temporal bone, histologically benign, but clinically behaves as malignant tumors causing destruction of surrounding tissues.
Kh.M.A. Diab +6 more
doaj +1 more source
Molecular architecture underlying fluid absorption by the developing inner ear
eLife, 2017 Mutations of SLC26A4 are a common cause of hearing loss associated with enlargement of the endolymphatic sac (EES). Slc26a4 expression in the developing mouse endolymphatic sac is required for acquisition of normal inner ear structure and function. Here,
Keiji Honda +11 more
doaj +1 more source
Epithelial cell stretching and luminal acidification lead to a retarded development of stria vascularis and deafness in mice lacking pendrin. [PDF]
PLoS ONE, 2011 Loss-of-function mutations of SLC26A4/pendrin are among the most prevalent causes of deafness. Deafness and vestibular dysfunction in the corresponding mouse model, Slc26a4(-/-), are associated with an enlargement and acidification of the membranous ...
Hyoung-Mi Kim, Philine Wangemann
doaj +1 more source
Endolymphatic sac surgery [PDF]
The Laryngoscope, 1977 AbstractThere is a disturbing variation in the reported success rate in Endolymphatic Sac Surgery in the literature. Relatively long‐term (24 months to 10 years) follow‐ups are given in a series of 66 patients in this paper. Results reveal only a 55% long‐term relief of veitigo in these patients.
openaire +3 more sources
Frontiers in Neurology, 2022 BackgroundPostauricular injection as a local therapy has been confirmed to be effective for inner ear diseases. However, the mechanism for the drugs entering the inner ears remains unknown.
Aiping Chen +7 more
doaj +1 more source
The Human Endolymphatic Sac and Inner Ear Immunity: Macrophage Interaction and Molecular Expression
Frontiers in Immunology, 2019 Background: The endolymphatic sac (ES) is endowed with a multitude of white blood cells that may trap and process antigens that reach the inner ear from nearby infection-prone areas, it thus serves as an immunologic defense organ.
Charlotta Kämpfe Nordström +4 more
semanticscholar +1 more source
Visualization and clinical relevance of the endolymphatic duct and sac in Ménière's disease
Frontiers in Neurology, 2023 BackgroundMénière's disease (MD) is a chronic inner ear disorder with a multifactorial etiology. Decreased visualization of the endolymphatic duct (ED) and sac (ES) is thought to be associated with MD, although controversy exists about whether this ...
Lisa M. H. de Pont +12 more
doaj +1 more source
Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter? [PDF]
PLoS ONE, 2018 INTRODUCTION:Middle ear application of gentamicin is a common medical treatment for uncontrolled Ménière's disease. The objective of the study was to evaluate the impact of endolymphatic hydrops on inner ear delivery.
Pedro Marques +3 more
doaj +1 more source
European Archives of Oto-Rhino-Laryngology, 2019 Background and purposeWe explored whether there was a difference between measurements obtained with CT and MRI for the diagnosis of large vestibular aqueduct syndrome or large endolymphatic sac anomaly, and whether this influenced diagnosis on the basis ...
Steve Connor +6 more
semanticscholar +1 more source